Search
for
Sort by
Research 571–600 of 1000+
- Medical Therapies
- In reply
- The Good and Bad News About New Drugs for Treating Alopecia Areata
- Prenatal diagnosis of a foetus with partial monosomy 4p and partial trisomy 13q
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Autophagy Stimulation Improves Erythroid Proliferative Capacity in Models of SF3B1 Mutant MDS
- Hair today, gone tomorrow
- PSS20 MEDIATION MODELING AND MEASUREMENT CHARACTERISTICS OF THE ITCH SEVERITY SCORE FROM A PHASE 2B TRIAL OF ORAL CP-690-550 IN PATIENTS WITH MODERATE TO-SEVERE PLAQUE PSORIASIS
- Les Rencontres d’Experts du Psoriasis : des recommandations pour la pratique quotidienne
- 63-Year-Old Female with Diffuse Thinning of the Hair
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- New Treatment Strategies in Management of Alopecia Areata: Review Article
- Ann Robinson’s research reviews —12 May 2022
- Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- A description of alopecia areata in European patients based on real-world survey data: physician-reported characterization of severity and associated treatment utilization
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Observation and consideration on using of JAKi in clinical trials in times of COVID ‐19
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition
- Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Emerging treatments in alopecia
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part II Systemic Treatment